Advanced search
1 file | 217.44 KB Add to list

Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation

(2010) BLOOD PURIFICATION. 30(4). p.277-287
Author
Organization
Keywords
Atherosclerosis, Chronic kidney disease, Guanidino compounds, SDMA, Uremic toxins, Vascular damage, CHRONIC-RENAL-FAILURE, UREMIC RETENTION SOLUTES, CORONARY-ARTERY-DISEASE, SOLUBLE L-SELECTIN, ASYMMETRICAL DIMETHYLARGININE, DIALYZED PATIENTS, P-CRESOL, HEMODIALYSIS, PLASMA, MORTALITY

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 217.44 KB

Citation

Please use this url to cite or link to this publication:

MLA
Schepers, Eva, Griet Glorieux, Laetitia Dou, et al. “Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in Vitro Evaluation.” BLOOD PURIFICATION 30.4 (2010): 277–287. Print.
APA
Schepers, E., Glorieux, G., Dou, L., Cerini, C., Gayrard, N., Louvet, L., Maugard, C., et al. (2010). Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation. BLOOD PURIFICATION, 30(4), 277–287.
Chicago author-date
Schepers, Eva, Griet Glorieux, Laetitia Dou, Claire Cerini, Nathalie Gayrard, Loïc Louvet, Charlotte Maugard, et al. 2010. “Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in Vitro Evaluation.” Blood Purification 30 (4): 277–287.
Chicago author-date (all authors)
Schepers, Eva, Griet Glorieux, Laetitia Dou, Claire Cerini, Nathalie Gayrard, Loïc Louvet, Charlotte Maugard, Pierre Preus, Maria Rodriguez-Ortiz, Angel Argiles, Philippe Brunet, Gerald Cohen, Joachim Jankowski, Vera Jankowski, Ziad Massy, Mariano Rodriguez, and Raymond Vanholder. 2010. “Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in Vitro Evaluation.” Blood Purification 30 (4): 277–287.
Vancouver
1.
Schepers E, Glorieux G, Dou L, Cerini C, Gayrard N, Louvet L, et al. Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation. BLOOD PURIFICATION. 2010;30(4):277–87.
IEEE
[1]
E. Schepers et al., “Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation,” BLOOD PURIFICATION, vol. 30, no. 4, pp. 277–287, 2010.
@article{1268752,
  author       = {Schepers, Eva and Glorieux, Griet and Dou, Laetitia and Cerini, Claire and Gayrard, Nathalie and Louvet, Loïc and Maugard, Charlotte and Preus, Pierre and Rodriguez-Ortiz, Maria and Argiles, Angel and Brunet, Philippe and Cohen, Gerald and Jankowski, Joachim and Jankowski, Vera and Massy, Ziad and Rodriguez, Mariano and Vanholder, Raymond},
  issn         = {0253-5068},
  journal      = {BLOOD PURIFICATION},
  keywords     = {Atherosclerosis,Chronic kidney disease,Guanidino compounds,SDMA,Uremic toxins,Vascular damage,CHRONIC-RENAL-FAILURE,UREMIC RETENTION SOLUTES,CORONARY-ARTERY-DISEASE,SOLUBLE L-SELECTIN,ASYMMETRICAL DIMETHYLARGININE,DIALYZED PATIENTS,P-CRESOL,HEMODIALYSIS,PLASMA,MORTALITY},
  language     = {eng},
  number       = {4},
  pages        = {277--287},
  title        = {Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation},
  url          = {http://dx.doi.org/10.1159/000320765},
  volume       = {30},
  year         = {2010},
}

Altmetric
View in Altmetric
Web of Science
Times cited: